Addiction, Substance
10
5
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Neuroimaging of Adolescent Cannabis Use Treatment
Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users
Efficiency of Prevention Program Dedicated to Addictive Behaviors (PREVENTURE) of Vulnerable Teenagers
Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)
Pain Clinic Provides Public Health Safety
Gamified Adaptive Approach Bias Modification on Individuals With Methamphetamine Use History
Evaluating the Effectiveness of Mobile Self-guided Psychological Interventions to Reduce Relapse in Substance Use Disorder
The Efficacy of a Mobile Application in Reducing Craving and Lapse Risk in Alcohol and Stimulants Problematic Use
Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment
Assessment of Severity and Outcome of Addicted Cases.